Lyndsay Harris
Program Leader · Case Western Reserve University/University Hospitals Cleveland Medical Center
Credentials: · · ·
History
Hematology and Medical Oncology
Internal Medicine
Research
Journal of Clinical Oncology · 2002 · 2,488 citations
Review · Journal of Clinical Oncology · 2007 · First of 10 authors · 1,705 citations
Molecular definition of breast tumor heterogeneity
Cancer Cell · 2007 · 1,084 citations
40 papers
- SH
38 papers
37 papers
36 papers
34 papers
- AC
Alice Chen
27 papers
26 papers
- EM
20 papers
Grants
- 2009–2012
Optimal Predictors of Response to Trastuzumab
National Cancer Institute · R01
PI · $1.2M · Yale University
- 2005–2010
Dana-Farber/Harvard SPORE in Breast Cancer
National Cancer Institute · P50
Project lead · $527K · Dana-Farber Cancer Inst
Clinical trials
- 2020–2027
National Cancer Institute "Cancer Moonshot Biobank"
Principal investigator · Active not recruiting
National Cancer Institute (NCI)
- 2020–2026
NCI COVID-19 in Cancer Patients, NCCAPS Study
Principal investigator · Active not recruiting
National Cancer Institute (NCI)
- 2002
Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)